Patents by Inventor Bronwen Jane Connor

Bronwen Jane Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170152477
    Abstract: The present invention is concerned with methods for reprogramming of mammalian somatic cells and in particular to reprogramming of mature mammalian somatic cells into multi-potent precursor cells.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicants: AUCKLAND UNISERVICES LIMITED, THE UNIVERSITY OF MELBOURNE
    Inventors: Bronwen Jane CONNOR, Mirella DOTTORI, Christof MAUCKSCH
  • Publication number: 20160122712
    Abstract: The present invention is concerned with methods for reprogramming of mammalian somatic cells and in particular to reprogramming of mature mammalian somatic cells into multi-potent precursor cells.
    Type: Application
    Filed: December 1, 2015
    Publication date: May 5, 2016
    Applicants: AUCKLAND UNISERVICES LIMITED, THE UNIVERSITY OF MELBOURNE
    Inventors: Bronwen Jane Connor, Mirella Dottori, Christof Maucksch
  • Patent number: 9228170
    Abstract: The present invention is concerned with methods for reprogramming of mammalian somatic cells and in particular to reprogramming of mature mammalian somatic cells into multi-potent precursor cells.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: January 5, 2016
    Assignees: AUCKLAND UNISERVICES LIMITED, THE UNIVERSITY OF MELBOURNE
    Inventors: Bronwen Jane Connor, Mirella Dottori, Christof Maucksch
  • Publication number: 20130190299
    Abstract: Methods and formulations for the treatment of multiple sclerosis with drugs with affinity for both serotonergic 5-HT2 and dopaminergic receptors such as the D2 receptor are herein disclosed. According to one embodiment, a method includes delivering a therapeutic dosage of drugs with affinity for both serotonergic 5-HT2 and dopaminergic receptors such as the D2 receptors to a subject exhibiting symptoms of multiple sclerosis to alleviate the symptoms.
    Type: Application
    Filed: June 28, 2011
    Publication date: July 25, 2013
    Applicant: Victoria Link Ltd.
    Inventors: Anne Camille La Flamme, Bronwen Jane Connor, David O'Sullivan
  • Publication number: 20120301965
    Abstract: The present invention is concerned with methods for reprogramming of mammalian somatic cells and in particular to reprogramming of mature mammalian somatic cells into multi-potent precursor cells.
    Type: Application
    Filed: February 4, 2011
    Publication date: November 29, 2012
    Applicants: THE UNIVERSITY OF MELBOURNE, AUCKLAND UNISERVICES LIMITED
    Inventors: Bronwen Jane Connor, Mirella Dottori, Christof Maucksch